Is KLTO a buy at 1.04

**Klotho Neurosciences (KLTO) is not a buy at $1.04**. Here's the analysis to support this conclusion: 1. **Technical Indicators**: KLTO's technical indicators are not favorable for a buying decision. The stock is currently trading below its 5-day, 10-day, and 20-day moving averages, which suggests a bearish trend. Additionally, the MACD is negative, the RSI is neutral, and the KDJ is in the oversold territory, indicating a lack of positive momentum. |code|Ticker|Name|Date|RSI|KDJ|MACD|market_code| |---|---|---|---|---|---|---|---| |KLTO|KLTO.O|Klotho Neurosciences|20250701|45.4825|38.3453|-0.1735|185| |code|Ticker|Name|Date|Moving Average|market_code| |---|---|---|---|---|---| |KLTO|KLTO.O|Klotho Neurosciences|20250701|1.0580|185| 2. **Financial Ratios**: The stock's P/E ratio, P/B ratio, and P/S ratio are not available. However, the absence of these ratios suggests that the company may not be profitable or may have a negative book value, which is not a favorable sign for investors. 3. **Market Sentiment**: Despite recent positive developments in the company's gene therapy pipeline and the acquisition of SB Security Holdings, LLC, the stock's price has experienced a significant drop, which may reflect investor concerns about the company's financial health and growth prospects. 4. **Regulatory Compliance**: KLTO is facing potential delisting from the Nasdaq Stock Market due to non-compliance with listing requirements, specifically the minimum bid price rule. This regulatory uncertainty is a red flag for investors. 5. **Strategic Position**: KLTO's strategic shift into the home security market through the acquisition of SB Security Holdings, LLC, is a positive sign for long-term growth. However, this does not change the company's current financial situation or growth prospects in its core biotech segment. In conclusion, KLTO is not a buy at $1.04. The company's financial situation and growth prospects do not support a buying decision, even at a lower price point. Investors should consider these factors and the company's long-term sustainability before making an investment decision.